ASA conducts virtual annual meeting, elects board members
BOZEMAN, Mont. Simmental and SimGenetic enthusiasts attended ASA’s 53rd Annual Meeting and Reception virtually. The ASA Board of Trustees met Jan. 28-29, to highlight each committee’s work from the previous year, most notably, the increase in whole birth group phenotypes and genotypes into the IGS Genetic Evaluation from the Calf Crop Genomics research project, members’ unfailing support of the 2020 National Classic in Brookings, S.D., the membership relief package, and a myriad of other committee projects.
During the annual Chairman’s Reception on Jan. 29, Randy Moody, New Market, Ala., was formally seated as chairman of the soard, succeeding Tim Curran, Ione, Calif. Also seated were Vice Chairman Barry Wesner, Chalmers, Ind., and Treasurer Steve Eichacker, Salem, S.D. Rounding out ASA’s five-member executive committee are JW Brune, Overbrook, Kan., and Tom Nelson, Wibaux, Mont.
Early growth investments in Asia and Chinese onshore RMB investments.
As long as investors keep these changing market dynamics in mind - and position their private equity portfolios across a broad range of return drivers – we think investments in the asset class remain highly attractive in 2021.
Impact investment
Philipp Müller, Chief Executive Officer, BlueOrchard:
Emerging markets ultimately fared better than many feared through the Covid-19 pandemic. The initial concerns were that, combined, the hit to trade and tourism, weaker commodity prices and slowing foreign direct investment (FDI) could prove disproportionately damaging for developing economies.
However, overall, emerging market (EM) responses to the pandemic proved effective. Lockdowns were consistent in most countries. Fiscal measures such as tax deferrals, public sector loans or capital injections into businesses were supportive. A weakening USD and monetary policy manoeuvres – from policy rate reductions, spe